[HTML][HTML] The Niemann-Pick type diseases–A synopsis of inborn errors in sphingolipid and cholesterol metabolism

FW Pfrieger - Progress in lipid research, 2023 - Elsevier
Disturbances of lipid homeostasis in cells provoke human diseases. The elucidation of the
underlying mechanisms and the development of efficient therapies represent formidable …

Regulation of sphingomyelin metabolism

K Bienias, A Fiedorowicz, A Sadowska… - Pharmacological …, 2016 - Elsevier
Sphingolipids (SFs) represent a large class of lipids playing diverse functions in a vast
number of physiological and pathological processes. Sphingomyelin (SM) is the most …

Platelet-derived microRNAs regulate cardiac remodeling after myocardial ischemia

JP Schütte, MC Manke, K Hemmen, P Münzer… - Circulation …, 2023 - Am Heart Assoc
Background: Platelets can infiltrate ischemic myocardium and are increasingly recognized
as critical regulators of inflammatory processes during myocardial ischemia and reperfusion …

[HTML][HTML] Physiological functions and therapeutic applications of neutral sphingomyelinase and acid sphingomyelinase

H Xiang, S Jin, F Tan, Y Xu, Y Lu, T Wu - Biomedicine & Pharmacotherapy, 2021 - Elsevier
Sphingomyelin (SM) can be converted into ceramide (Cer) by neutral sphingomyelinase
(NSM) and acid sphingomyelinase (ASM). Cer is a second messenger of lipids and can …

[HTML][HTML] Inhibition of acid sphingomyelinase by tricyclic antidepressants and analogons

N Beckmann, D Sharma, E Gulbins, KA Becker… - Frontiers in …, 2014 - frontiersin.org
Amitriptyline, a tricyclic antidepressant, has been used in the clinic to treat a number of
disorders, in particular major depression and neuropathic pain. In the 1970s the ability of …

Macrophage migration inhibitory factor limits activation-induced apoptosis of platelets via CXCR7-dependent Akt signaling

M Chatterjee, O Borst, B Walker, A Fotinos… - Circulation …, 2014 - Am Heart Assoc
Rationale: Macrophage migration inhibitory factor (MIF) is released on platelet activation.
Circulating MIF could potentially regulate platelets and thereby platelet-mediated …

Sphingolipids and glycerophospholipids–the “ying and yang” of lipotoxicity in metabolic diseases

S Rodriguez-Cuenca, V Pellegrinelli, M Campbell… - Progress in lipid …, 2017 - Elsevier
Sphingolipids in general and ceramides in particular, contribute to pathophysiological
mechanisms by modifying signalling and metabolic pathways. Here, we present the …

Identification of key lipids critical for platelet activation by comprehensive analysis of the platelet lipidome

B Peng, S Geue, C Coman, P Münzer… - Blood, The Journal …, 2018 - ashpublications.org
Platelet integrity and function critically depend on lipid composition. However, the lipid
inventory in platelets was hitherto not quantified. Here, we examined the lipidome of murine …

Glycoprotein VI-novel target in antiplatelet medication

O Borst, M Gawaz - Pharmacology & therapeutics, 2021 - Elsevier
Subendothelial collagen exposed to platelets after rupture of atherosclerotic plaques is the
main trigger of platelet activation und acute arterial thrombotic occlusion leading to …

Multiple sclerosis: melatonin, orexin, and ceramide interact with platelet activation coagulation factors and gut-microbiome-derived butyrate in the circadian …

G Anderson, M Rodriguez, RJ Reiter - International journal of molecular …, 2019 - mdpi.com
Recent data highlight the important roles of the gut microbiome, gut permeability, and
alterations in mitochondria functioning in the pathophysiology of multiple sclerosis (MS) …